메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Accro Bioscience to Present Phase II Data of AC-201 for Plaque Psoriasis at the European Academy of Dermatology & Venereology Congress 2025 in Paris

NEW YORK and SUZHOU, China, Sept. 4, 2025 -- Accro Bioscience (Accropeutics), a clinical-stage biotech company focused on molecular mechanisms of regulated cell death and related pathogenesis in human diseases, today announced that it will present results from a Phase II clinical study evaluating AC-201, an oral, selective TYK2/JAK1 Inhibitor, in moderate-to-severe plaque psoriasis, at the European Academy of Dermatology & Venereology (EADV) Congress, being held September 17-20th, in Paris. Details of the presentation are as follows:Abstract Type: Oral Presentation in the Late Brea
- 김갑성 기자
- 2025-09-04 20:24
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

LEHI, Utah, Sept. 4, 2025 -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced that the Company plans to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference. Jared Bearss, Chief Operating Officer of Halia, will provide a business overview presentation on Tuesday, September 9, 2025 at 7:00 am ET. About Halia Therapeutics Halia Therapeutics is a clinical-stage biopharmaceutical company focused on treating the root causes of inflammation. Leveraging geneti
- 김갑성 기자
- 2025-09-04 20:00
Angel Yeast Protein Receives U.S. GRAS Certification, Opening the Door to Broader Access to Sustainable Protein

SHANGHAI, Sept. 4, 2025 -- Angel Yeast (SH600298), a leading global provider of yeast and fermentation-based ingredients, announced today that its proprietary yeast protein, AngeoPro, has been granted Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administration (FDA). The designation not only affirms the safety of the product but also marks a significant milestone in Angel Yeast's effort to expand the role of sustainable yeast protein in the global food supply. Positioned as a solution to challenges such as food security, climate change, and the
- 김갑성 기자
- 2025-09-04 20:00
Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States

The LuMon™ System is also CE-marked under EU MDR and registered with TGA in Australia. LINCOLN, R.I., Sept. 4, 2025 -- Sentec, a global leader in non-invasive patient monitoring, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon™ Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent, and adult patients—making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients. The LuMon™ EIT System delivers functional lu
- 김갑성 기자
- 2025-09-04 19:00
UNSW and NeuRA Lead New Study to Explore How ReNeuWell® App Supports Mental Wellbeing

SYDNEY, Sept. 4, 2025 -- A clinical trial is being launched by researchers from UNSW and Neuroscience Research Australian (NeuRA) for a new app called ReNeuWell®, based on a scientifically validated measure of wellbeing. The application has been designed in collaboration with a research team led by A/Professor Justine Gatt from UNSW's School of Psychology and NeuRA. It uses the COMPAS-W Wellbeing Scale - which measures both subjective and psychological wellbeing, a scale developed by A/Prof Justine Gatt and that has been validated in neuroscience. Miroma Project Factory, sp
- 김갑성 기자
- 2025-09-04 06:23
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

[ 메디채널 김갑성 기자 ] Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows Illumina's announcement of agreement to acquire SomaLogic SAN DIEGO, Sept. 3, 2025 -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS) based proteomics discove
- 김갑성 기자
- 2025-09-03 21:15
SPS Expands Philips SpeechLive with Ambient Medical AI Documentation, Powered by Corti

VIENNA, Austria and COPENHAGEN, Denmark, Sept. 3, 2025 -- Speech Processing Solutions (SPS), the global leader behind Philips SpeechLive, today announced a strategic partnership with Corti, the specialized AI infrastructure company for healthcare, to introduce ambient clinical documentation directly into the SpeechLive platform. This partnership integrates Corti's real-time medical reasoning engine into the SpeechLive AI Assistant - transforming the trusted dictation platform into a fully AI-powered documentation ecosystem. As the only platform that brings together dictation, s
- 김갑성 기자
- 2025-09-03 20:53
Global Bio Conference 2025 kicks off in Seoul, charting biotech's future

SEOUL, South Korea, Sept. 3, 2025 -- This is an article published in The Korea Herald: The Ministry of Food and Drug Safety announced Wednesday that it kicked off Global Bio Conference 2025, under the theme "Bio, Navigating Infinite Possibilities." The conference will be held from Wednesday to Friday at the Grand InterContinental Seoul Parnas in southern Seoul. Celebrating its 11th year, GBC has established itself as a leading global platform, bringing together approximately 5,000 participants each year from regulatory authorities, the pharmaceutical industry a
- 김갑성 기자
- 2025-09-03 20:00
Acer Expands SpatialLabs Pro Ecosystem with Immersive 3D Capabilities Across Multiple Verticals

Editor's Summary Integration with NVIDIA Omniverse libraries via OpenXR runtime supports enhanced spatial awareness for industrial designs and simulations Partnership with Video Engineering brings 3D stereo microscopy to inspection, design, and prototyping workflows Collaboration with Smart Surgery for medical training allows for high-resolution, glasses-free analysis on SpatialLabs' 3D displays BERLIN, Sept. 3, 2025 -- Acer today announced significant advancements in its SpatialLabs™ Pro solution, unveiling new integrations with NVIDIA Omniverse, Video Engineer
- 김갑성 기자
- 2025-09-03 17:40
Acer Medical Unveils aiMed Ahead of IFA 2025, Showcasing the Future of AI in Healthcare

BERLIN, Sept. 3, 2025 -- Acer Medical, an Acer Group company specializing in medical imaging and AI-powered healthcare solutions, unveiled aiMed, its next-generation generative AI medical documentation system at the next@acer global press conference, ahead of IFA 2025 in Berlin. The milestone underscores Acer Medical's expanding global footprint and its commitment to transforming healthcare through AI and digital innovation. aiMed directly addresses one of the most pressing challenges in modern healthcare —clinical documentation overload. On average, healthcare providers spend up to 25
- 김갑성 기자
- 2025-09-03 17:30

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2025-11-05_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 05일 07시 20분